Emerald Health
An Exceptional Team with a Unique Spin -- CFN Media - Seite 2
Building upon this research, the company has developed a product line with a high level of genetic and product diversity. Core products include CBX (CBG, CBC, THCV, CBDV), CBD ( > 3% CBD), THC:CBD (THC=CBD), THC ( < 17% THC), and THC+ ( > 17% THC). These products enable different patients to access the right concentrations for their needs, such as a patient that's only looking for CBD without psychoactive THC.
The company also intends to conduct clinical trials of its own to demonstrate the utility of its broad product lines. With these study results in hand, the company will be able to effectively convince more doctors to prescribe the drug as a treatment for various indications. Proprietary cannabinoid drugs that have undergone clinical trials will also command a significant premium in the market and set the company apart from other licensed producers.
Please follow the link to read the full article:
http://www.cannabisfn.com/emerald-health-exceptional-team-unique-spin/
For more information, visit the company's website or CannabisFN's company profile.
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media
visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Lesen Sie auch
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause
actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is
not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC
may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek
their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.
Contact:
Frank Lane
206.369.7050
flane@cannabisfn.com